VIDEO + AUDIO
VIDEO
-
Symposium – Understanding the JAK/STAT Pathway and Burden of Atopic Dermatitis
-
Product Theater – CIMZIA® (certolizumab pegol): An Anti-TNF for Skin and Joint Relief in Biologic-Experienced Patients
-
Sun Pharma and DPAF lead the effort in PA-directed research
-
Tough Legislative Issues and the new “SDPA Member Spotlight”
-
What I Didn’t Learn in Residency
-
Ocular Dermatology
AUDIO
DERMCAST PRO
-
Symposium – Understanding the JAK/STAT Pathway and Burden of Atopic Dermatitis
Peter A. Lio, MD, Founding Director of the Chicago Integrative Eczema Center reviews the disease state and burden of AD, discusses the integral components in the pathophysiology of AD, and describes the role of the JAK/STAT pathway in AD during this symposium, sponsored by Pfizer, from the recent SDPA DIGITAL […]
November 30, 2020
-
Inpatient Dermatology Survival Guide
Faculty: Robert Micheletti, MD – Philadelphia, PA Assistant Professor of Dermatology and Medicine, University of Pennsylvania Director of the Cutaneous Vasculitis Clinic, Penn Vasculitis Center Medical training, Duke University School of Medicine Dr. Micheletti discusses the impact of dermatology consultation on the care of medically complex hospitalized […]
January 13, 2021
-
Gum disease as indicator of skin disease
Periodontitis, also known as gum disease, is a gum infection that can damage the soft tissue and lead to the destruction of the bone that supports the teeth. It is typically caused by an overgrowth of microbes which leads to an immune-inflammatory response. Dental plaque is a common contributing factor […]
